Elanco Animal Health
ELAN
371 hedge funds and large institutions have $9.05B invested in Elanco Animal Health in 2020 Q1 according to their latest regulatory filings, with 63 funds opening new positions, 170 increasing their positions, 90 reducing their positions, and 88 closing their positions.
89% more repeat investments, than reductions
Existing positions increased: 170 | Existing positions reduced: 90
21% more call options, than puts
Call options by funds: $36M | Put options by funds: $29.9M
2.39% more ownership
Funds ownership: 99.06% → 101.45% (+2.4%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
7% less funds holding
Funds holding: 400 → 371 (-29)
17% less capital invested
Capital invested by funds: $10.9B → $9.05B (-$1.83B)
28% less first-time investments, than exits
New positions opened: 63 | Existing positions closed: 88
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$571M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$364M |
| 3 |
Aristotle Capital Management
Los Angeles,
California
|
+$298M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$107M |
| 5 |
Primecap Management
Pasadena,
California
|
+$105M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lazard Asset Management
New York
|
-$418M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$167M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$102M |
| 4 |
CG
Carmignac Gestion
Paris,
France
|
-$79.7M |
| 5 |
JP Morgan Chase
New York
|
-$78.8M |
ELAN Hedge Fund Activity: Q1 2020 in Review
371 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q1 2020, worth a combined $9.05B — down 17% from $10.9B a quarter earlier.
Sellers outnumbered buyers: 88 funds closed out of ELAN and 63 opened new positions — a net loss of 25 holders — while 90 trimmed existing stakes and 170 added.
The largest buyer was Janus Henderson Group, adding an estimated $571M. The largest seller was Lazard Asset Management, exiting entirely with an estimated $418M sold.
- 371 institutional investors held Elanco Animal Health (ELAN) as of Q1 2020, down from 400 in Q4 2019.
- Funds reported $9.05B of Elanco Animal Health stock for Q1 2020, down 17% quarter-over-quarter.
- 63 funds opened new Elanco Animal Health positions in Q1 2020 and 88 closed out, a net change of -25 holders.
- The largest Elanco Animal Health buyer in Q1 2020 was Janus Henderson Group, an estimated $571M added.
- The largest Elanco Animal Health seller in Q1 2020 was Lazard Asset Management, an estimated $418M sold.
Based on aggregated 13F filings for Q1 2020.